Declassifying diabetes

2006/07/05 by E. A. M. Gale, E.A.M. Gale · 71 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Diabetes Management and Research #Diabetes and associated disorders #Diabetes mellitus #Diet and metabolism studies #Endocrinology #Human physiology #Internal medicine #Medicine

paper · pdf · doi:10.1007/s00125-006-0348-7

published in Diabetologia 49(9), 1989-1995 (Springer Science+Business Media)

openalex publication_date 2006/07/05 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/05

Cited by

• Type 2 diabetes subtypes for precision medicine: methodological challenges and alternative prediction-based approaches
• 2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2022
• 2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
• On the intergenerational transfer of ideas in aging and cancer research: from the hypothalamus according to V.M. Dilman to the mTOR protein complex according to M.V. Blagosklonny
• 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025
• 2. Diagnosis and Classification of Diabetes:Standards of Care in Diabetes—2024
• 2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2021
• Epidemiology of type 1 diabetes. [europepmc]
• Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth study. [europepmc]
• What is type 2 diabetes? [europepmc]
• Predictors of associated autoimmune diseases in families with type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. [europepmc]
• Levels of C-peptide, body mass index and age, and their usefulness in classification of diabetes in relation to autoimmunity, in adults with newly diagnosed diabetes in Kronoberg, Sweden. [europepmc]
• Does diabetes appear in distinct phenotypes in young people? Results of the diabetes mellitus incidence Cohort Registry (DiMelli). [europepmc]
• Utility of diabetes-associated autoantibodies for classification of new onset diabetes in children and adolescents. [europepmc]
• Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth. [europepmc]
• Double-diabetes in a real-world sample of 2711 individuals: associated with insulin treatment or part of the heterogeneity of type 1 diabetes? [europepmc]
• Painting a new picture of personalised medicine for diabetes. [europepmc]
• Human genetics as a model for target validation: finding new therapies for diabetes. [europepmc]
• Double or hybrid diabetes: A systematic review on disease prevalence, characteristics and risk factors. [europepmc]
• Metabolic Syndrome: A Narrative Review from the Oxidative Stress to the Management of Related Diseases. [europepmc]
• On the intergenerational transfer of ideas in aging and cancer research: from the hypothalamus according to V.M. Dilman to the mTOR protein complex according to M.V. Blagosklonny. [europepmc]